NeoGenomics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $91.1M | $172.0M | $12.8M |
| FY2018 | $92.9M | $320.4M | $9.8M |
| FY2019 | $95.0M | $507.4M | $173.0M |
| FY2020 | $169.1M | $694.3M | $228.7M |
| FY2021 | $532.6M | $1.11B | $316.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $91.1M | $172.0M | $12.8M |
| FY2018 | $92.9M | $320.4M | $9.8M |
| FY2019 | $95.0M | $507.4M | $173.0M |
| FY2020 | $169.1M | $694.3M | $228.7M |
| FY2021 | $532.6M | $1.11B | $316.8M |